Samuel T. Barnett
Directeur/Membre du Conseil chez Friends Life Care Partners
Profil
Samuel T.
Barnett is currently a Director at Friends Life Care Partners.
Previously, he was a Director at Astralis Ltd.
from 2004 to 2007.
He holds a graduate degree and a doctorate from Temple University (Pennsylvania) and an undergraduate degree from Wesleyan University.
Postes actifs de Samuel T. Barnett
| Sociétés | Poste | Début |
|---|---|---|
Friends Life Care Partners
 Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Samuel T. Barnett
| Sociétés | Poste | Fin |
|---|---|---|
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Directeur/Membre du Conseil | 07/03/2007 |
Formation de Samuel T. Barnett
| Wesleyan University | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
Friends Life Care Partners
Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA. | Health Services |
